research Persistent Or New Symptoms 1 Year After A Single High Dose Of Vitamin D3 In Patients With Moderate To Severe COVID-19
High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.
Search
for
Sort by
Research
270-300 / 698 resultsresearch Knowledge and Beliefs About the Use and Abuse of Oral Contraceptive Pills Among Males: A Mixed-Method Explanatory Sequential Study in Community Pharmacy Settings
Many men misuse oral contraceptive pills for things like hair growth and muscle gain.
research Does Nirmatrelvir/Ritonavir Influence the Immune Response Against SARS-CoV-2 Independently From Rebound?
Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.
research SARS-CoV-2 Infection as a Trigger for Telogen Effluvium: A Literature Review with Case-Based Clinical Evaluation Guidance
COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.
research Letter in Reply: Alopecia Areata After SARS-CoV-2 Vaccination
A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.
research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study
COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.
research Telogen Effluvium After COVID-19 Infection: A Narrative Review of the Physiological Mechanism
COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.
research New Onset of Alopecia Areata in a Patient with SARS-CoV-2 Infection: Possible Pathogenetic Correlations
COVID-19 infection may trigger alopecia areata in some patients.
research Acute Telogen Effluvium Associated with SARS-CoV-2 Infection
A woman's sudden hair loss was linked to her previous COVID-19 infection.
research A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection
COVID-19 may trigger sudden temporary hair loss.
research Telogen Effluvium in the New SARS-CoV-2 Era
COVID-19 and related stress may increase hair loss known as Telogen effluvium.
research TMPRSS2, Required for SARS-CoV-2 Entry, Is Downregulated in Lung Cells by Enzalutamide, a Prostate Cancer Therapeutic
A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.
research Telogen Effluvium as a Symptom of Long Covid in Pre-Infected SARS-CoV-2 Patients: An Integrative Literature Review
Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.
research Spironolactone: An Anti-Androgenic and Anti-Hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Spironolactone might help protect against severe lung problems in COVID-19 patients.
research Enzalutamide, a Prostate Cancer Therapeutic, Downregulates TMPRSS2 in Lung and Reduces Cellular Entry of SARS-CoV-2
Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.
research Olive Oil Regenerates Hair Lost During Alopecia Complication Caused by SARS-CoV-2 Infection and Vaccination
Olive oil can help regrow hair lost due to COVID-19 or vaccination.
research Diffused Alopecia Followed by Severe Acute Respiratory Syndrome Coronavirus-2 Infection
A woman's hair loss improved with treatment after a COVID-19 infection.
research Neurological Post-Acute Sequelae of SARS-CoV-2 Infection
Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.
research Asymptomatic SARS-CoV-2 Infection or COVID-19 Vaccination Effect for Severe Multisystem Inflammatory Syndrome in a 6-Year-Old Girl: Case Report and Review of the Literature
COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.
research The Effectiveness of Microneedling in the Treatment of Post-COVID-19 Hair Disorders
Microneedling therapy is effective and safe for treating hair disorders worsened by COVID-19.
research Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?
Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.
research Covid-19 in Lupus Nephritis
Patients with lupus nephritis and COVID-19 can improve with proper treatment.
research Long COVID: Current Status in Japan and Knowledge About Its Molecular Background
Long COVID in Japan involves persistent symptoms like fatigue and may be caused by lasting organ damage and prolonged inflammation, with vaccination as a potential treatment.
research Pathogenesis, Clinical Manifestations, and Laboratory Findings of COVID-19
COVID-19 affects multiple body systems and complicates treatment; accurate testing is crucial.
research Sequelae of Long Covid, Known and Unknown: A Review of Updated Information
The review indicates that understanding of long COVID symptoms is still limited and better research is needed for diagnosis and treatment.
research Comment on: The Gabrin Sign
The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.
research Androgen Sensitivity Gateway to COVID-19 Disease Severity
Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.
research Impact of Anti-Androgen Therapies on COVID-19 Susceptibility: A Case-Control Study in Male Population from Two COVID-19 Regional Centers of Lombardy, Italy
Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.
research Drug-Induced Lupus or Systemic Lupus Erythematosus After Experimental COVID-19 Therapy: Difficulties in Differential Diagnosis
Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.
research Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes
COVID-19-related hair loss may have unique features compared to hair loss from other causes.